{"transactions":[{"id":858733,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Medical and Innovation Ofr"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T16:32:22.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":73340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":73340,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":73340},"source":{"system":"sec-edgar","filing":"0001811030-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000181103026000003/primarydocument.xml","form_type":"4"}},{"id":858732,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Medical and Innovation Ofr"}}],"security":"Ordinary Shares","published_at":"2026-03-05T16:32:22.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":6412,"price":13.3054,"value":85314.2248,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price."}],"balance_after":267190,"source":{"system":"sec-edgar","filing":"0001811030-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000181103026000003/primarydocument.xml","form_type":"4"}},{"id":858731,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Medical and Innovation Ofr"}}],"security":"Ordinary Shares","published_at":"2026-03-05T16:32:22.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":50125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal  parts on the first, second and third  anniversary of the grant date, subject to the reporting person's continued employment through such dates."}],"balance_after":273602,"source":{"system":"sec-edgar","filing":"0001811030-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000181103026000003/primarydocument.xml","form_type":"4"}},{"id":867960,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Medical and Innovation Ofr"}}],"security":"Ordinary Shares","published_at":"2026-03-03T16:11:29.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":3272,"price":13.3273,"value":43606.9256,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $13.31 USD to $13.36 USD; the price reported above reflects the weighted average sale price."}],"balance_after":223477,"source":{"system":"sec-edgar","filing":"0001811030-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000181103026000002/primarydocument.xml","form_type":"4"}},{"id":867959,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Medical and Innovation Ofr"}}],"security":"Ordinary Shares","published_at":"2026-03-03T16:11:29.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":12992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents vesting of performance-based restricted stock units."}],"balance_after":226749,"source":{"system":"sec-edgar","filing":"0001811030-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000181103026000002/primarydocument.xml","form_type":"4"}},{"id":867958,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Medical and Innovation Ofr"}}],"security":"Ordinary Shares","published_at":"2026-03-03T16:11:29.000Z","date":"2026-02-27","kind":"sale","planned":false,"acquired":false,"shares":7461,"price":13.8395,"value":103256.5095,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.79 USD to $13.91 USD; the price reported above reflects the weighted average sale price."}],"balance_after":213757,"source":{"system":"sec-edgar","filing":"0001811030-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000181103026000002/primarydocument.xml","form_type":"4"}},{"id":1219739,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-03-06T16:41:30.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":81499,"price":18.19,"value":1482466.81,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 81,499 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates."}],"balance_after":81499,"derivative":{"exercise_price":18.19,"exercise_date":"2026-03-04","expiration_date":"2035-03-03","underlying":"Ordinary Shares","underlying_shares":81499},"source":{"system":"sec-edgar","filing":"0001562180-25-002160","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000156218025002160/primarydocument.xml","form_type":"4"}},{"id":1219738,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-06T16:41:30.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":54975,"price":18.19,"value":999995.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates."}],"balance_after":221218,"source":{"system":"sec-edgar","filing":"0001562180-25-002160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000156218025002160/primarydocument.xml","form_type":"4"}},{"id":1229179,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T16:19:23.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":268,"price":18.9217,"value":5071.0156,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On the transaction date, the reporting person sold 268 shares in multiple trades at prices ranging from $18.8304 to $18.94.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":166243,"source":{"system":"sec-edgar","filing":"0001562180-25-001977","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000156218025001977/primarydocument.xml","form_type":"4"}},{"id":1236032,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T21:27:07.000Z","date":"2025-02-28","kind":"sale","planned":false,"acquired":false,"shares":311,"price":18.3128,"value":5695.2808,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 28, 2025, the reporting person sold 311 shares in multiple trades at prices ranging from $18.30 to $18.316.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":166511,"source":{"system":"sec-edgar","filing":"0001562180-25-001917","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000156218025001917/primarydocument.xml","form_type":"4/A","original_submission_date":"2025-03-03"}},{"id":1236031,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T21:27:07.000Z","date":"2025-02-28","kind":"sale","planned":false,"acquired":false,"shares":4326,"price":18.7827,"value":81253.9602,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 28, 2025, the reporting person sold 4,326 shares in multiple trades at prices ranging from $18.73 to $18.86.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":166822,"source":{"system":"sec-edgar","filing":"0001562180-25-001917","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000156218025001917/primarydocument.xml","form_type":"4/A","original_submission_date":"2025-03-03"}},{"id":1236030,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T16:28:29.000Z","date":"2025-02-28","kind":"sale","planned":false,"acquired":false,"shares":311,"price":18.3128,"value":5695.2808,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 28, 2025, the reporting person sold 311 shares in multiple trades at prices ranging from $18.30 to $18.316. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":166511,"source":{"system":"sec-edgar","filing":"0001562180-25-001837","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000156218025001837/primarydocument.xml","form_type":"4"}},{"id":1236029,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T16:28:29.000Z","date":"2025-02-28","kind":"sale","planned":false,"acquired":false,"shares":4326,"price":18.7827,"value":81253.9602,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2025, the reporting person sold 4,326 shares in multiple trades at prices ranging from $18.73 to $18.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":166822,"source":{"system":"sec-edgar","filing":"0001562180-25-001837","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000156218025001837/primarydocument.xml","form_type":"4"}},{"id":1610154,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-02-29T16:35:31.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":125078,"price":16.3,"value":2038771.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 125,078 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates."}],"balance_after":125078,"derivative":{"exercise_price":16.3,"exercise_date":"2025-02-27","expiration_date":"2034-02-26","underlying":"Ordinary Shares","underlying_shares":125078},"source":{"system":"sec-edgar","filing":"0001562180-24-001986","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000156218024001986/primarydocument.xml","form_type":"4"}},{"id":1610153,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Ordinary Shares","published_at":"2024-02-29T16:35:31.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":81799,"price":16.3,"value":1333323.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates."}],"balance_after":171148,"source":{"system":"sec-edgar","filing":"0001562180-24-001986","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000156218024001986/primarydocument.xml","form_type":"4"}},{"id":1834026,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Ordinary Shares","published_at":"2023-07-06T16:15:10.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":305,"price":35.28,"value":10760.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January1, 2023 through June 30, 2023.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2023."}],"balance_after":89349,"source":{"system":"sec-edgar","filing":"0001562180-23-005762","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000156218023005762/primarydocument.xml","form_type":"4"}},{"id":1969342,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-06T16:43:05.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":3936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents vesting of performance-based restricted stock units."}],"balance_after":89044,"source":{"system":"sec-edgar","filing":"0001562180-23-002494","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000156218023002494/primarydocument.xml","form_type":"4"}},{"id":1969341,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-06T16:43:05.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":28830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents vesting of performance-based restricted stock units."}],"balance_after":85108,"source":{"system":"sec-edgar","filing":"0001562180-23-002494","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000156218023002494/primarydocument.xml","form_type":"4"}},{"id":1979859,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2023-03-02T16:58:34.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":21607,"price":76.97,"value":1663090.79,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 21,607 ordinary shares will vest and become exercisable in equal installments on each of February 28, 2024, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates."}],"balance_after":21607,"derivative":{"exercise_price":76.97,"exercise_date":"2024-02-28","expiration_date":"2033-02-27","underlying":"Ordinary Shares","underlying_shares":21607},"source":{"system":"sec-edgar","filing":"0001645113-23-000029","document":"wf-form4_167779429653064.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511323000029/wf-form4_167779429653064.xml","form_type":"4"}},{"id":1979858,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-02T16:58:34.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":12992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest on February 28, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates."}],"balance_after":56278,"source":{"system":"sec-edgar","filing":"0001645113-23-000029","document":"wf-form4_167779429653064.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511323000029/wf-form4_167779429653064.xml","form_type":"4"}},{"id":2058998,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2023-01-09T18:24:06.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":1946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":1946,"derivative":{"exercise_price":47.04,"expiration_date":"2029-03-21","underlying":"Ordinary Shares","underlying_shares":1946},"source":{"system":"sec-edgar","filing":"0001645113-23-000010","document":"wf-form4_167330663055285.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511323000010/wf-form4_167330663055285.xml","form_type":"4"}},{"id":2058997,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2023-01-09T18:24:06.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":1201,"price":120,"value":144120.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg."}],"balance_after":43286,"source":{"system":"sec-edgar","filing":"0001645113-23-000010","document":"wf-form4_167330663055285.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511323000010/wf-form4_167330663055285.xml","form_type":"4"}},{"id":2058996,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2023-01-09T18:24:06.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":2617,"price":108,"value":282636.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg."}],"balance_after":44487,"source":{"system":"sec-edgar","filing":"0001645113-23-000010","document":"wf-form4_167330663055285.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511323000010/wf-form4_167330663055285.xml","form_type":"4"}},{"id":2058995,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2023-01-09T18:24:06.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":1946,"price":120,"value":233520.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg."}],"balance_after":47104,"source":{"system":"sec-edgar","filing":"0001645113-23-000010","document":"wf-form4_167330663055285.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511323000010/wf-form4_167330663055285.xml","form_type":"4"}},{"id":2058994,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2023-01-09T18:24:06.000Z","date":"2023-01-05","kind":"exercise","acquired":true,"shares":1946,"price":47.04,"value":91539.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg."}],"balance_after":49050,"source":{"system":"sec-edgar","filing":"0001645113-23-000010","document":"wf-form4_167330663055285.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511323000010/wf-form4_167330663055285.xml","form_type":"4"}},{"id":2058993,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2023-01-09T18:24:06.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":2379,"price":120,"value":285480.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg."}],"balance_after":47104,"source":{"system":"sec-edgar","filing":"0001645113-23-000010","document":"wf-form4_167330663055285.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511323000010/wf-form4_167330663055285.xml","form_type":"4"}},{"id":2210821,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2022-07-07T17:51:03.000Z","date":"2022-07-05","kind":"grant","acquired":true,"shares":281,"price":59.075,"value":16600.075,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2022 through June 30, 2022.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amended total to correct prior mathematical error."}],"balance_after":49483,"source":{"system":"sec-edgar","filing":"0001645113-22-000066","document":"wf-form4_165723064834354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511322000066/wf-form4_165723064834354.xml","form_type":"4"}},{"id":2348162,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-03-07T18:25:21.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":4961,"price":80.59,"value":399806.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options to buy 4,961 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":4961,"derivative":{"exercise_price":80.59,"exercise_date":"2023-03-01","expiration_date":"2032-02-29","underlying":"Ordinary Shares","underlying_shares":4961},"source":{"system":"sec-edgar","filing":"0001645113-22-000021","document":"wf-form4_164669550591279.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511322000021/wf-form4_164669550591279.xml","form_type":"4"}},{"id":2348161,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-03-07T18:25:21.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":30422,"price":80.59,"value":2451708.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Options to buy 30,422 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates."}],"balance_after":30422,"derivative":{"exercise_price":80.59,"exercise_date":"2023-03-01","expiration_date":"2032-02-29","underlying":"Ordinary Shares","underlying_shares":30422},"source":{"system":"sec-edgar","filing":"0001645113-22-000021","document":"wf-form4_164669550591279.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511322000021/wf-form4_164669550591279.xml","form_type":"4"}},{"id":2348160,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-07T18:25:21.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":17371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest on March 1, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates."}],"balance_after":49186,"source":{"system":"sec-edgar","filing":"0001645113-22-000021","document":"wf-form4_164669550591279.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511322000021/wf-form4_164669550591279.xml","form_type":"4"}},{"id":2436907,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-12T17:41:04.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":35,"price":63.818,"value":2233.63,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2021 through December 31, 2021.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2021."}],"balance_after":31815,"source":{"system":"sec-edgar","filing":"0001645113-22-000008","document":"wf-form4_164202724976066.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511322000008/wf-form4_164202724976066.xml","form_type":"4"}},{"id":2638349,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-08T17:38:19.000Z","date":"2021-07-06","kind":"grant","acquired":true,"shares":113,"price":137.122,"value":15494.786,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2021 through June 30, 2021.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2021."}],"balance_after":31780,"source":{"system":"sec-edgar","filing":"0001645113-21-000089","document":"wf-form4_162578028082781.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511321000089/wf-form4_162578028082781.xml","form_type":"4"}},{"id":2716759,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-05-12T16:13:45.000Z","date":"2021-05-10","kind":"exercise","acquired":false,"shares":3846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":3845,"derivative":{"exercise_price":47.56,"expiration_date":"2029-05-07","underlying":"Ordinary Shares","underlying_shares":3846},"source":{"system":"sec-edgar","filing":"0001645113-21-000066","document":"wf-form4_162085040881642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511321000066/wf-form4_162085040881642.xml","form_type":"4"}},{"id":2716758,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-12T16:13:45.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":1804,"price":189.65,"value":342128.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg."}],"balance_after":31667,"source":{"system":"sec-edgar","filing":"0001645113-21-000066","document":"wf-form4_162085040881642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511321000066/wf-form4_162085040881642.xml","form_type":"4"}},{"id":2716757,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-12T16:13:45.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":3846,"price":189.65,"value":729393.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg."}],"balance_after":33471,"source":{"system":"sec-edgar","filing":"0001645113-21-000066","document":"wf-form4_162085040881642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511321000066/wf-form4_162085040881642.xml","form_type":"4"}},{"id":2716756,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-12T16:13:45.000Z","date":"2021-05-10","kind":"exercise","acquired":true,"shares":3846,"price":47.56,"value":182915.76,"ownership":{"direct":true},"balance_after":37317,"source":{"system":"sec-edgar","filing":"0001645113-21-000066","document":"wf-form4_162085040881642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511321000066/wf-form4_162085040881642.xml","form_type":"4"}},{"id":2752186,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2021-04-09T16:25:33.000Z","date":"2021-03-23","kind":"sale","acquired":false,"shares":2835,"price":140,"value":396900.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Amending original form 4 filed on March 25, 2021 to add additional transaction inadvertently omitted."},{"field":"shares","element":"transactionShares","label":"F2","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Weinberg."}],"balance_after":33471,"source":{"system":"sec-edgar","filing":"0001645113-21-000051","document":"wf-form4a_161799991891111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511321000051/wf-form4a_161799991891111.xml","form_type":"4/A","original_submission_date":"2021-03-25"}},{"id":2772097,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-03-25T16:40:08.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":3892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":3892,"derivative":{"exercise_price":47.04,"expiration_date":"2029-03-21","underlying":"Ordinary Shares","underlying_shares":3892},"source":{"system":"sec-edgar","filing":"0001645113-21-000048","document":"wf-form4_161670479191751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511321000048/wf-form4_161670479191751.xml","form_type":"4"}},{"id":2772096,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-25T16:40:08.000Z","date":"2021-03-23","kind":"sale","acquired":false,"shares":3892,"price":140,"value":544880.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Weinberg."}],"balance_after":36306,"source":{"system":"sec-edgar","filing":"0001645113-21-000048","document":"wf-form4_161670479191751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511321000048/wf-form4_161670479191751.xml","form_type":"4"}},{"id":2772095,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-25T16:40:08.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":3892,"price":47.04,"value":183079.68,"ownership":{"direct":true},"balance_after":40198,"source":{"system":"sec-edgar","filing":"0001645113-21-000048","document":"wf-form4_161670479191751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511321000048/wf-form4_161670479191751.xml","form_type":"4"}},{"id":2809187,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-03-04T17:54:25.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":16003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 16,003 ordinary shares will vest and become exercisable in equal installments on each of March 2, 2022, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates."}],"balance_after":16003,"derivative":{"exercise_price":153.09,"expiration_date":"2031-03-01","underlying":"Ordinary Shares","underlying_shares":16003},"source":{"system":"sec-edgar","filing":"0001645113-21-000032","document":"wf-form4_161489844997400.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511321000032/wf-form4_161489844997400.xml","form_type":"4"}},{"id":2809186,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-04T17:54:25.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":8709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on each of March 2, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":36306,"source":{"system":"sec-edgar","filing":"0001645113-21-000032","document":"wf-form4_161489844997400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511321000032/wf-form4_161489844997400.xml","form_type":"4"}},{"id":2836162,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-02-24T16:16:55.000Z","date":"2021-02-22","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001645113-21-000015","document":"wf-form4_161420137542064.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511321000015/wf-form4_161420137542064.xml","form_type":"4"}},{"id":2836161,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-24T16:16:55.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":6500,"price":175.5,"value":1140750.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg."}],"balance_after":27597,"source":{"system":"sec-edgar","filing":"0001645113-21-000015","document":"wf-form4_161420137542064.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511321000015/wf-form4_161420137542064.xml","form_type":"4"}},{"id":2836160,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-24T16:16:55.000Z","date":"2021-02-22","kind":"exercise","acquired":true,"shares":6500,"price":7.15,"value":46475.0,"ownership":{"direct":true},"balance_after":34097,"source":{"system":"sec-edgar","filing":"0001645113-21-000015","document":"wf-form4_161420137542064.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511321000015/wf-form4_161420137542064.xml","form_type":"4"}},{"id":3021760,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-09-28T18:13:27.000Z","date":"2020-09-25","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":6500,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001645113-20-000141","document":"wf-form4_160133119236559.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511320000141/wf-form4_160133119236559.xml","form_type":"4"}},{"id":3021759,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-09-28T18:13:27.000Z","date":"2020-09-25","kind":"exercise","acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":11.46,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001645113-20-000141","document":"wf-form4_160133119236559.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511320000141/wf-form4_160133119236559.xml","form_type":"4"}},{"id":3021758,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2020-09-28T18:13:27.000Z","date":"2020-09-25","kind":"sale","acquired":false,"shares":6500,"price":103.35,"value":671775.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Weinberg."}],"balance_after":27597,"source":{"system":"sec-edgar","filing":"0001645113-20-000141","document":"wf-form4_160133119236559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511320000141/wf-form4_160133119236559.xml","form_type":"4"}},{"id":3021757,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2020-09-28T18:13:27.000Z","date":"2020-09-25","kind":"exercise","acquired":true,"shares":6500,"price":7.15,"value":46475.0,"ownership":{"direct":true},"balance_after":34097,"source":{"system":"sec-edgar","filing":"0001645113-20-000141","document":"wf-form4_160133119236559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511320000141/wf-form4_160133119236559.xml","form_type":"4"}},{"id":3021756,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2020-09-28T18:13:27.000Z","date":"2020-09-25","kind":"sale","acquired":false,"shares":8750,"price":103.35,"value":904312.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Weinberg."}],"balance_after":27597,"source":{"system":"sec-edgar","filing":"0001645113-20-000141","document":"wf-form4_160133119236559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511320000141/wf-form4_160133119236559.xml","form_type":"4"}},{"id":3021755,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2020-09-28T18:13:27.000Z","date":"2020-09-25","kind":"exercise","acquired":true,"shares":8750,"price":11.46,"value":100275.0,"ownership":{"direct":true},"balance_after":36347,"source":{"system":"sec-edgar","filing":"0001645113-20-000141","document":"wf-form4_160133119236559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511320000141/wf-form4_160133119236559.xml","form_type":"4"}},{"id":3039590,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-09-03T16:43:11.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":3779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to buy 3,779 ordinary shares will vest and become exercisable in equal installments on each of September 1, 2021, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":3779,"derivative":{"exercise_price":84.68,"expiration_date":"2030-08-31","underlying":"Ordinary Shares","underlying_shares":3779},"source":{"system":"sec-edgar","filing":"0001645113-20-000125","document":"wf-form4_159916577557277.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511320000125/wf-form4_159916577557277.xml","form_type":"4"}},{"id":3039589,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Restricted Share Units","published_at":"2020-09-03T16:43:11.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":1968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on September 1, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amended total to correct prior mathematical error."}],"balance_after":27597,"source":{"system":"sec-edgar","filing":"0001645113-20-000125","document":"wf-form4_159916577557277.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511320000125/wf-form4_159916577557277.xml","form_type":"4"}},{"id":3086775,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-08T16:20:55.000Z","date":"2020-07-07","kind":"grant","acquired":true,"shares":325,"price":50.405,"value":16381.625,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2020 through June 30, 2020.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2020."}],"balance_after":30357,"source":{"system":"sec-edgar","filing":"0001645113-20-000093","document":"wf-form4_159423964284425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511320000093/wf-form4_159423964284425.xml","form_type":"4"}},{"id":3154750,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Restricted Share Units","published_at":"2020-05-11T16:22:09.000Z","date":"2020-05-08","kind":"exercise","acquired":false,"shares":1402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Fully vested as of the date hereof."}],"balance_after":2803,"derivative":{"exercise_price":0,"exercise_date":"2020-05-08","underlying":"Ordinary Shares","underlying_shares":1402},"source":{"system":"sec-edgar","filing":"0001645113-20-000075","document":"wf-form4_158922851155255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511320000075/wf-form4_158922851155255.xml","form_type":"4"}},{"id":3154749,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-11T16:22:09.000Z","date":"2020-05-08","kind":"exercise","acquired":true,"shares":1402,"price":63.84,"value":89503.68,"ownership":{"direct":true},"balance_after":25629,"source":{"system":"sec-edgar","filing":"0001645113-20-000075","document":"wf-form4_158922851155255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000164511320000075/wf-form4_158922851155255.xml","form_type":"4"}}]}